The DDA has invited all drug companies to register under WHO-GMP within mid-April 2012, The Himalayan Times reported.
With the introduction of the norms, it will be obligatory for the drug manufacturers to maintain and meet certain conditions such as similar procedures and conditions.
DDA director Radha Prasad said the department is drafting the regulations to upgrade the standard of Nepali pharmaceutical companies to attain international recognition.